Physician profile
Mark Steven Givan
NPI 1114035581
$1,550.84
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $213 · 2021: $128 · 2022: $265 · 2023: $486 · 2024: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545 · Consulting Fee: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.81 |
| Consulting Fee | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $704.56 | 2021-2024 | Itero Element 5d Plus, Invisalign, Invisalign First - Comprehensive Phase 2 |
| Biohorizons Implant Systems INC. | $308.37 | 2020-2024 | Biohorizons |
| Dentsply LLC | $200.00 | 2023 | |
| Dentsply Sirona INC | $137.25 | 2019-2020 | |
| Centrix INC | $60.08 | 2019 | |
| Straumann USA LLC | $50.00 | 2019 | |
| Henry Schein, INC. | $42.09 | 2019 | |
| Philips North America LLC | $15.99 | 2021 | |
| 3m Company | $12.90 | 2021 | |
| Gc America INC. | $12.79 | 2022 | |
| Ultradent Products INC | $6.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Givan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.